Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
January 22, 2021	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-21-014727.pdf 0001193125-21-014727.rtf 0001193125-21-014727.xls View HTML
January 12, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-006769.pdf 0001193125-21-006769.rtf 0001193125-21-006769.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
December 15, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-317577.pdf 0001193125-20-317577.rtf 0001193125-20-317577.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
December 2, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-308391.pdf 0001193125-20-308391.rtf 0001193125-20-308391.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 10, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000902219-20-000435.pdf 0000902219-20-000435.rtf 0000902219-20-000435.xls View HTML
November 5, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-286276.pdf 0001193125-20-286276.rtf 0001193125-20-286276.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 5, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-20-015733.pdf 0001628280-20-015733.rtf 0001628280-20-015733.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 13, 2020	SC 13G/A	An amendment to the SC 13G filing	0000093751-20-000964.pdf 0000093751-20-000964.rtf View HTML
October 9, 2020	SC 13G/A	An amendment to the SC 13G filing	0001567619-20-017709.pdf 0001567619-20-017709.rtf 0001567619-20-017709.xls View HTML
September 25, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-253955.pdf 0001193125-20-253955.rtf 0001193125-20-253955.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax